[Federal Register Volume 74, Number 207 (Wednesday, October 28, 2009)]
[Notices]
[Page 55586]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-26003]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 18, 2009, Archimica, 
Inc., 2460 W. Bennett Street, Springfield, Missouri 65807-1229, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of Tapentadol (9780), a basic 
class of controlled substance listed in schedule II.
    The company plans to manufacture the listed controlled substance in 
bulk for distribution to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than December 28, 2009.

     Dated: October 21, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-26003 Filed 10-27-09; 8:45 am]
BILLING CODE 4410-09-P